Where does Ovid Therapeutics Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ovid Therapeutics Inc. ranks #6,581 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ovid Therapeutics Inc. hold?

Ovid Therapeutics Inc. holds 51 US utility patents granted between 2016 and 2025, spanning 4 technology areas.

What is Ovid Therapeutics Inc.'s Innovation Score?

Ovid Therapeutics Inc. has an Innovation Score of 34.3 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ovid Therapeutics Inc. focus on?

Ovid Therapeutics Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 48 patents, ranking #456 of 7,163 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Ovid Therapeutics Inc.'s patent grant rate increasing or decreasing?

Ovid Therapeutics Inc.'s recent grant velocity is +38% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Ovid Therapeutics Inc.'s patents?

Ovid Therapeutics Inc.'s patents average 15.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ovid Therapeutics Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Ovid Therapeutics Inc.

USPTO PatentsView assignee record - 51 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ovid ranks #6,581 of 49,997 tracked US assignees by granted-patent volume, with 51 patents across 4 technology areas.

#6,581
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.3/100): 15.5
avg claims per patent: +38%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6581 · US Corporation #6,581 · 51 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 51 grants
UPPER-Q #6,581/49,997
PHOTO-FINISH Nokia Solutions and…
CPC-NARROW A61K · 4 areas
INNOV-THIN 34.3/100
CLAIMS-RICH 15.5 claims/avg
TYPE-USCORP US Corporation
VEL-UP +38% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nokia Solutions and Networks GmbH & Co. KG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ovid’s 34.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.6 pts (40%) Velocity 4.2 pts (12%) Breadth 7.1 pts (21%) Claim depth 9.3 pts (27%)

Qualcomm Incorporated · highest

85
Tyto Care · near

34
Yangzhou Jiuyi… · near

34
Keysight Singapore… · near

34
Ovid Therapeutics · this assignee

34
StoreBound · near

34
3D Lighting… · lowest

7

What this shows Ovid's Innovation Score is 34.3/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ovid?

Each dot is one of Ovid’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ovid’s own 15.5 claims/patent is at or below the 16.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Ovid vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ovid's grants concentrate

Ovid Therapeutics Inc. is a focused PatentsView assignee: 4 CPC subclasses with 94.1% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (11 grants) versus a trough of 4 in 2016. By volume, Ovid sits between Nokia Solutions and Networks GmbH & Co. KG and Optum Technology, Inc..

Ovid's three-year grant acceleration

From 2019–2021 to 2022–2024, Ovid Therapeutics Inc. moved from 22 to 14 grants (0.64x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Nokia Solutions a…

51
Nokomis

51
Optical Logic

51
Orion Energy Syst…

51
Oerlikon Metco (U…

51
Olympus Scientifi…

51
Oneevent

51
Optum Technology

51
Ovid Therapeutics ◀

51

What this shows Ovid holds 51 patents at rank #6,577, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ovid

By rank, the assignees closest to #6,577 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Ovid's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ovid, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Ovid ranks #456 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Keysight Technologies Singapore (SALES) Pte. Ltd. 34 Tyto Care Ltd. 34 Yangzhou Jiuyi Hardware & Machinery Co., Ltd. 34 StoreBound LLC 34

Similar claim depth

Nearest assignees by average claims per patent (15.5 here).

The University of Western Australia 15.5 avg Fermi Research Alliance, LLC 15.5 avg Wangsu Science AND Technology Co., Ltd. 15.5 avg Constellation Pharmaceuticals, Inc. 15.5 avg

Ovid's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Ovid Therapeutics Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	4	7.8%
2017	6	11.8%
2018	4	7.8%
2019	7	13.7%
2020	11	21.6%
2021	4	7.8%
2022	4	7.8%
2023	5	9.8%
2024	5	9.8%
2025partial year	1	2.0%

Which technologies does Ovid Therapeutics Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 48

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 42

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

C07C - Acyclic OR Carbocyclic Compounds 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ovid Therapeutics Inc.'s patent record in context - here's where to go next.

Ovid Therapeutics Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 94.1% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #6,581 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ovid Therapeutics Inc. against Nokia Solutions and Networks GmbH & Co. KG, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.